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Members of the Forkhead boxO (Foxo) family of tran-
scription factors are key regulators of cellular
responses, but their function in the immune system
remains incompletely understood. Here we showed
that T cell-specific deletion of Foxo1 gene in mice
led to spontaneous T cell activation, effector T cell
differentiation, autoantibody production, and the
induction of inflammatory bowel disease in a transfer
model. In addition, Foxo1 was critical for the mainte-
nance of naive T cells in the peripheral lymphoid
organs. Transcriptome analyses of T cells identified
Foxo1-regulated genes encoding, among others,
cell-surface molecules, signaling proteins, and
nuclear factors that control gene expression. Func-
tional studies validated interleukin-7 receptor-a as
a Foxo1 target gene essential for Foxo1maintenance
of naive T cells. These findings reveal crucial func-
tions of Foxo1-dependent transcription in control of
T cell homeostasis and tolerance.
INTRODUCTION
T lymphocytes are well maintained in the peripheral lymphoid
organs under the immune system steady state (Jameson,
2002; Surh and Sprent, 2005). Survival and homeostatic prolifer-
ation of T cells is primarily mediated by the cytokine interleukin 7
(IL-7) (Ma et al., 2006; Schluns and Lefrancois, 2003), in part via
IL-7 control of expression of target genes including the prosur-
vival factor Bcl-2 (Akashi et al., 1997; Maraskovsky et al.,
1997), and through IL-7 regulation of protein stability of the
cyclin-dependent kinase inhibitor p27Kip1 (Barata et al., 2001;
Li et al., 2006a). IL-7 exerts its biological effects by binding to
the IL-7 receptor complex composed of IL-7 receptor-a chain
(IL-7R) and the common g-chain, resulting in the activation of
the Stat5 transcription factor (Jiang et al., 2005). Neutralization
of IL-7 results in compromised survival of mature T cells (Schluns
et al., 2000; Tan et al., 2001), whereas transgenic expression of
IL-7 expands T cells (Kieper et al., 2002). Memory T cells also fail
to flourish in IL-7-deficient mice (Kondrack et al., 2003; Li et al.,358 Immunity 30, 358–371, March 20, 2009 ª2009 Elsevier Inc.2003; Schluns et al., 2000; Seddon et al., 2003), emphasizing
a prerequisite for IL-7 in control of T cells at various differentia-
tion states. IL-7 is constitutively produced by stromal cells, and
the control of IL-7 signaling is largely through the regulation of
IL-7R expression in T cells (Mazzucchelli and Durum, 2007).
Indeed, IL-7R is not detectable on CD4+CD8+ immature T cells
but is expressed on positively selected mature CD4+ and CD8+
T cells. IL-7R is downregulated upon T cell activation but is re-
expressed on memory T cells. Several transcription factors
including GABP and Gfi-1 have been shown to regulate IL-7R
expression in T cells (Chandele et al., 2008; Park et al., 2004;
Xue et al., 2004; Yucel et al., 2003). However, the mechanisms
that control IL-7R expression at the various stages of T cell differ-
entiation remain incompletely understood.
The stochastic process by which the T cell receptors are
generated creates the inherent problem that some receptors
have a high affinity for self-antigens or for innocuous environ-
mental antigens such as those from commensal organisms.
Multiple mechanisms have evolved to control T cell-mediated
immunopathology, including deletion of self-reactive T cell
clones in the thymus and active immune suppression by cytokine
TGF-b1 or CD4+CD25+Foxp3+ regulatory T cells in the periphery
(Li and Flavell, 2008; Mathis and Benoist, 2004; Sakaguchi et al.,
2008). In addition to these cell-extrinsic mechanisms, it has been
postulated that peripheral T cell tolerance might be regulated by
T cell-intrinsic factors including the Forkhead boxO (Foxo) family
of transcription factors (Yusuf and Fruman, 2003).
Foxo proteins (Foxo1, Foxo3a, Foxo4, and Foxo6) are
mammalian homologs of the Caenorhabditis elegans transcrip-
tion factor DAF-16, which have critical functions in control of
cellular responses (Burgering, 2008). Foxo activity is downregu-
lated by protein kinase B (PKB)-mediated phosphorylation that
triggers nuclear export of Foxo proteins (Huang and Tindall,
2007). In resting T cells, Foxo proteins reside in the nucleus.
PKB activation via the stimulation of the T cell receptor, CD28,
and cytokine signaling pathways inactivates Foxo proteins,
which is associated with the induction of T cell proliferation
(Peng, 2008). Indeed, ectopic expression of a PKB-insensitive
Foxo1 mutant suppresses T cell proliferation (Fabre et al.,
2005; Medema et al., 2000), suggesting that inactivation of
Foxo1 is an obligatory step for T cells to enter the cell cycle.
Deletion of Foxo3a gene in mice results in a mild lymphoprolifer-
ative syndrome and the development of inflammatory lesions
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activation and differentiation. The functions of the other Foxo
family proteins in control of T cell responses in vivo remain to
be determined.
To investigate the definitive function of Foxo1 in T cells, we
generated mice with T cell-specific deletion of the Foxo1 gene.
Thymic T cell differentiation did not appear to be compromised
in the absence of Foxo1. However, in the periphery, increased
numbers of Foxo1-deficient T cells exhibited an activated pheno-
type and differentiated into effector T cells, concomitant with the
inductionof autoantibody. In addition, splenic naiveTcell number
was reduced in Foxo1-deficient mice. Gene expression profiling
of naive T cells revealed novel Foxo1 target genes including Il7r.
Indeed, expression of IL-7R protein was markedly diminished in
Foxo1-deficient naive T cells. Foxo1-deficient naive T cells
were refractory to IL-7-induced survival in vitro and exhibited
compromised homeostatic proliferation in vivo. Bone marrow
chimera experiments revealed that diminished IL-7R expression
wasa consequence of intrinsic defects of Foxo1-deficient T cells,
which was in line with the observation that Foxo1 bound to the
evolutionarily conserved regulatory sequences of Il7r gene in
wild-type T cells. Foxo1-deficient OT-II T cells exhibited a naive
T cell phenotype, expressed undetectable amounts of IL-7R,
and were depleted from the peripheral lymphoid organs. Re-
expression of IL-7R on these cells rescued OT-II T cell number
in the periphery. These findings demonstrated a critical role for
Foxo1 in control of T cell tolerance and of naive T cell homeo-
stasis through the induction of IL-7R expression.
RESULTS
Generation of Mice with T Cell-Specific Deletion
of Foxo1 Gene
The embryonic lethal phenotype of mice with a germline deletion
of Foxo1 gene prohibited their usage in the study of T cells
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Figure 1. Generation of Mice with T Cell-
Specific Deletion of the Foxo1 Gene
(A) Schematic presentation of original allele (+), tar-
geting vector, the recombinant allele, and the
floxed allele (Foxo1). Filled boxes represent the
first exon of Foxo1 gene. The locations of restric-
tion enzyme sites (Xb, XbaI) are indicated. Loxp
and Frt sites are shown as arrowheads and filled
circles, respectively.
(B) PCR genotyping of the floxed Foxo1 allele and
the original allele.
(C) CD4+ T cells, CD8+ T cells, and B cells were
purified from Foxo1/Foxo1 (wild-type, WT) and
CD4Cre-Foxo1/Foxo1 (knockout, KO) mice by
FACS sorting. The amounts of Foxo1 and p38
were determined by immunoblotting. p38 was
used as a loading control.
(Furuyama et al., 2004; Hosaka et al.,
2004). To investigate the cell type-
specific function of Foxo1 in vivo, we
generated mice with a mutated Foxo1
allele by the insertion of two loxP sites
flanking its promoter region and the first exon (Figure 1A). The
translation start codon of Foxo1 protein resides in exon 1. Dele-
tion of exon 1 was therefore expected to create a null mutation
of Foxo1 gene. loxP sites were introduced into the Foxo1 locus
by homologous recombination in mouse embryonic stem (ES)
cells. ES cell clones carrying the recombinant Foxo1 locus
were used for generating chimeric mice that produced heterozy-
gous mice after germline transmission. These heterozygous
mice were bred with a strain of FLP1 recombinase transgenic
mice, which led to the excision of the neomycin-resistant gene
(Neo) flanked by the frt sites, and the creation of a floxed
Foxo1 allele (Figure 1B).
Mice with two floxed Foxo1 alleles developed normally and did
not show any sign of disease. These mice, designated as wild-
type (WT), were used as the control group in our analysis. To
study the function of Foxo1 in T cells, we crossed mice carrying
the two floxed Foxo1 alleles with CD4-Cre transgenic mice, in
which Cre is specifically expressed in T cells (Lee et al., 2001).
These mice are designated here as Foxo1-deficient mice.
Foxo1 protein was not detectable in either CD4+ or CD8+
T cells isolated from Foxo1-deficient mice (Figure 1C), whereas
B cells from these mice expressed comparable amounts of
Foxo1 to those from WT mice (Figure 1C). These observations
reveal efficient and specific ablation of Foxo1 protein in T cells
from Foxo1-deficient mice.
T Cell Development in the Absence of T Cell Foxo1
To investigate the consequences of loss of Foxo1 in T cells, we
first evaluated thymic T cell development in Foxo1-deficient
mice aged between 6 and 8 weeks. The CD4 and CD8 profile
of Foxo1-deficient thymocytes was not drastically different
from that of WT thymocytes, although a slight increase of TCR-
bhiCD4+ and TCR-bhiCD8+ mature T cells was observed (Figures
2A and 2B). We further examined CD69 and CD62L expression
in these T cells and found that upregulation of CD62L wasImmunity 30, 358–371, March 20, 2009 ª2009 Elsevier Inc. 359
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cient mice (Figures 2A and 2C). These findings are in line with
a recent study showing that the expression of a constitutively
active form of Foxo1 in human T cells induces CD62L expres-
sion, which has been associated with Foxo1 induction of the
transcription factor Kruppel-like factor 2 (KLF2) (Fabre et al.,
2008). KLF2 is an important regulator of T cell migration (Carlson
et al., 2006; Sebzda et al., 2008) and additionally controls the
expression of multiple T cell maturation marker proteins
including b7 integrin, CD69, and CD24 (Carlson et al., 2006).
However, unlike KLF2-deficient T cells, expression of these




Figure 2. T Cell Development in Foxo1-Defi-
cient Mice
(A) Thymic CD4 and CD8 profile of Foxo1/Foxo1
(wild-type, WT) and CD4Cre-Foxo1/Foxo1
(knockout, KO) mice at 6 weeks old. CD69 and
CD62L were measured for TCR-bhiCD4+ and
TCR-bhiCD8+ single-positive (SP) thymocytes by
flow cytometry. These are representative results
of eight mice per group analyzed from five inde-
pendent experiments.
(B) Number of thymic CD4+CD8+ (double-positive,
DP), TCR-bhiCD4+ SP, and TCR-bhiCD8+ SP cells
in control (Foxo1/Foxo1) and KO mice (n = 8) at
6–8 weeks old. Each circle represents the cell
number from an individual mouse, and the bar
represents the mean cell number. The p values
between two groups of T cell number are shown.
(C) Expression of CD62L, b7 integrin, CD69, and
CD24 in thymocytes from WT and KO mice at
6 weeks old. These are representative results of
four mice per group analyzed.
cient T cells (Figure 2C). Taken together,
these observations reveal a specific role
for Foxo1 in promoting CD62L expression
in mature CD4+ and CD8+ thymocytes in
mice.
T Cell Activation and Autoimmunity
in T Cell Foxo1-Deficient Mice
A previous study of Foxo3a-deficient
mice showed that Foxo3a is essential for
the inhibition of T cell activation and
effector T cell differentiation (Lin et al.,
2004). To investigate the function of
Foxo1 in control of peripheral T cells, we
first examined the expression of T cell
activation markers CD44, CD62L, and
CD69 in CD4+ and CD8+ T cells isolated
from the spleens of WT and Foxo1-defi-
cient mice. Compared to WT T cells,
a higher percentage of Foxo1-deficient
T cells exhibited an activated
CD44hiCD62Llo or CD69+ phenotype
(Figures 3A and 3C). Notably, similar to
Foxo1-deficient thymic mature T cells,
the CD44lo naive CD4+ and CD8+ T cells from Foxo1-deficient
mice expressed lower amounts of CD62L than did control
T cells from WT mice (Figures 3A and 3C). Increased T cell acti-
vation and decreasedCD62L expression in naive T cells was also
observed in the lymph nodes of Foxo1-deficient mice (Figures S1
and S2 available online). In addition, Foxo1-deficient mice devel-
oped lymphadenopathy associated with the expansion of CD4+
T cells that expressed high amounts of the proliferating cell
marker Ki-67 antigen (Figures S1 and S2). The cellularity of
Foxo1-deficient spleens was not markedly different from that
of WT spleens (data not shown). However, spleens from
Foxo1-deficient mice had increased number of CD4+ and360 Immunity 30, 358–371, March 20, 2009 ª2009 Elsevier Inc.
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whereas the number of CD44loCD62Lhi naive CD4+ and CD8+
T cells was decreased (Figure 3B). In addition to conventional
CD4+ and CD8+ T cells, CD4+CD8+ immature T cells also give
rise to a CD4+CD25+ regulatory T (Treg) cell lineage that
expresses the transcription factor Foxp3 (Sakaguchi et al.,
2008). CD4+CD25+Foxp3+ Treg cells are essential regulators of
peripheral T cell tolerance. To determine whether enhanced
T cell activation in Foxo1-deficient mice was caused by the
depletion of Treg cells, we examined these cells in the thymus
and in the periphery. A comparable percentage of Foxp3-posi-
tive Treg cells was found in both WT and Foxo1-deficient mice
in all lymphoid organs examined (Figure 3D; Figure S1). To inves-
tigate whether Foxo1 deficiency affected Treg cell function, we
crossed Foxo1-deficient mice with Foxp3-RFP reporter mice
(Wan and Flavell, 2005) and isolated Treg cells on the basis of
RFP expression. Foxo1-deficient Treg cells inhibited naive
T cell proliferation as potently as did WT Treg cells in an
in vitro assay (Figure S3). Taken together, these findings suggest
a cell-intrinsic function for Foxo1 in the maintenance of naive
phenotype T cells and in the prevention of T cell activation.
Foxo1-deficient CD4+ and CD8+ T cells also expressed higher
amounts of surface CD122 (Figure 3C), the shared receptor for
IL-2 and IL-15 (Ma et al., 2006). We and others have shown
that CD122 expression is controlled by transcription factors
T-bet and eomesodermin that also regulate Th1 and cytotoxic
T lymphocyte (CTL) differentiation (Intlekofer et al., 2005; Li
et al., 2006b). To determine effector T cell differentiation in
Foxo1-deficient mice, we stimulated T cells from spleens with
PMA and ionomycin for 4 hr and performed intracellular cytokine
staining. Compared to T cells from WT mice, which had only
a few CD4+ and CD8+ T cells capable of producing effector cyto-
kines IFN-g, IL-4, IL-10, and IL-17, a higher percentage of CD4+
and CD8+ T cells from Foxo1-deficient mice produced these
cytokines (Figure 3E). A similar increase in the number of cyto-
kine-producing T cells was also observed in the lymph nodes
of Foxo1-deficient mice (Figures S1 and S2). To determine
whether the increased cytokine production of Foxo1-deficient
T cells was a consequence of enhanced T cell activation, we
determined the frequency of cytokine-producing T cells among
the activated CD44hi T cells from WT and Foxo1-deficient
mice. A higher percentage of Foxo1-deficient CD4+CD44hi
T cells produced IFN-g or IL-17 than did WT CD4+CD44hi
T cells, whereas IL-4- or IL-10-producing CD4+ T cells or IFN-
g-producing CD8+ T cells were comparable among the activated
WT and Foxo1-deficient T cells (Figure S4). These observations
suggest that in addition to Foxo1 control of T cell activation,
Foxo1 plays a major role in inhibiting Th1 and Th17 cell differen-
tiation. To investigate whether this enhanced T cell differentiation
would trigger immunopathology, we aged a cohort of Foxo1-
deficient mice for 5–6 months. Histopathological examination
did not reveal drastic inflammation in any of the major organs
(data not shown). We also measured the amounts of autoreac-
tive antibodies in these mice. Increased titers of both nuclear
and dsDNA antibodies were detected in the sera of Foxo1-defi-
cient mice (Figure 3F). These observations demonstrate that
T cell Foxo1 is essential for the inhibition of effector T cell differ-
entiation and for the maintenance of B cell tolerance to self-
antigens.Foxo1-Dependent Transcriptional Program in Naive
T Cells
Wewished to identify Foxo1 target genes that are involved in the
control of T cell homeostasis and tolerance. To this end, we puri-
fied naive phenotype (CD44loCD62LhiCD25) CD4+ and CD8+
T cells from WT and Foxo1-deficient mice by FACS sorting.
RNA was prepared from these cells and was analyzed by global
gene expression profiling with the Affymetrix oligonucleotide
arrays. Comparing WT and Foxo1-deficient CD4+ T cells, 396
entries showed equal or greater than 2-fold change, whereas
497 entries differed in CD8+ T cells (Figure 4A, for a complete
list see Tables S1 and S2). Among the differentially expressed
entries, 187were sharedbetweenCD4+andCD8+Tcells (Figures
4B and 4C, for a complete list see Table S3). We initially focused
our analysis on these coregulated genes, which encode (among
others) cell-surface molecules, nuclear factors, and proteins
involved in the signal transduction and metabolism (Figure 4C).
Notably, the expression of genes encoding positive regulators
of T cell activation and differentiation such as Tnfrsf9, Gadd45 g,
and Rora was increased in Foxo1-deficient T cells (Figure 4C;
Lu et al., 2001; Vinay and Kwon, 1998; Yang et al., 2008). In addi-
tion, Foxo1controls theexpressionof genes involved in cell adhe-
sion, cell migration, and cellular stress responses (Figure 4C).
These findings reveal diverse Foxo1 target genes in T cells that
may collectively control T cell homeostasis and tolerance.
Foxo1 Regulation of IL-7R Expression and IL-7 Signaling
in T Cells
We focused on one of the Foxo1 target genes, Il7r, which was
downregulated in both CD4+ and CD8+ Foxo1-deficient T cells
(Figure 4C). In line with the gene expression results, Foxo1-defi-
cient CD4+ andCD8+CD44loCD62Lhi naive T cells expressed low
to undetectable amounts of IL-7R (CD127) protein (Figure 5A,
left). IL-7R expression is induced in the thymocytes that undergo
positive selection (Mazzucchelli and Durum, 2007). In contrast to
the upregulation of IL-7R in WT thymocytes, Foxo1-deficient
CD4+ and CD8+ T cells expressed increasingly lower amounts of
IL-7R when theymatured fromCD69+CD62Llo to CD69CD62Lhi
T cells (Figure 5B). IL-7R expression was also greatly diminished
in the activated CD44hi Foxo1-deficient T cells (Figure 5A, right).
These observations reveal a critical role for Foxo1 in control of
IL-7R expression at multiple stages of T cell differentiation.
The IL-7-IL-7R pathway is a pivotal regulator of T cell homeo-
stasis, which is in part mediated by its induction of the prosur-
vival Bcl2 gene expression (Akashi et al., 1997; Maraskovsky
et al., 1997). Consistent with the reduced IL-7R expression,
Foxo1-deficient CD4+ and CD8+ T cells expressed lower
amounts of Bcl-2 protein than did WT T cells (Figure 5C). IL-7
engagement of IL-7R activates JAK3 and JAK1 kinases that
phosphorylate the Stat5 transcription factor (Jiang et al., 2005).
Unlike WT naive T cells, IL-7 stimulation of Foxo1-deficient
T cells failed to induce Stat5 phosphorylation (Figure 5D). IL-7
is a potent regulator of naive T cell survival. Stimulation of WT
CD4+ or CD8+ naive T cells with IL-7 triggered dose-dependent
inhibition of cell apoptosis assessed with Annexin V staining
(Figure 5E). However, both CD4+ and CD8+ Foxo1-deficient
naive T cells were refractory to IL-7-induced survival in vitro
(Figure 5E). In vivo, IL-7 regulates the survival and homeostatic
proliferation of naive T cells (Ma et al., 2006). To investigate theImmunity 30, 358–371, March 20, 2009 ª2009 Elsevier Inc. 361
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Figure 3. T Cell Activation and Differentiation in Foxo1-Deficient Mice
(A) Expression of CD44 and CD62L in splenic CD4+ and CD8+ T cells from Foxo1/Foxo1 (wild-type, WT) and CD4Cre-Foxo1/Foxo1 (knockout, KO) mice at
6 weeks old. These are representative results of six independent experiments.
(B) The number of splenic CD4+ and CD8+ naive (CD44loCD62Lhi) and activated (CD44hiCD62Llo) T cells from control (Foxo1/Foxo1) and KO mice (n = 6) at 6–8
weeks old. The p values between two groups of T cell number are shown.
(C) Expression of CD62L, CD69, and CD122 in splenic CD4+ and CD8+ T cells fromWT and KOmice at 6 weeks old. These are representative results of six mice
per group analyzed.
362 Immunity 30, 358–371, March 20, 2009 ª2009 Elsevier Inc.
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a transfer experiment. We purified wild-type naive CD4+ or
CD8+ T cells from C57BL/6 mice that expressed the congenic
marker CD45.1. These T cells were mixed with Foxo1-deficient
naive T cells expressing the congenic marker CD45.2 at approx-
imately 1:1 ratio (Figure 5F, top), labeled with CFSE, and trans-
ferred to Rag1/ recipients. The usage of the CD45 marker
enabled us to differentiate WT and Foxo1-deficient T cells. After
7 days, T cells were recovered from the spleens and lymph
nodes of the recipient mice and assessed for cell proliferation
by CFSE dilution. We found that the recovery of Foxo1-deficient
T cells was about 10%–20% of the WT T cells, which was asso-
ciated with the compromised homeostatic proliferation of
Foxo1-deficient T cells (Figure 5F). These observations further
corroborated that the IL-7R expression defect of Foxo1-deficient
T cells caused compromised IL-7 signaling and IL-7-induced
T cell survival and proliferation.
A Cell-Intrinsic Role for Foxo1 in Control
of IL-7R Expression in T Cells
IL-7R expression is subject to regulation by multiple envi-
ronmental cues such as the presence of other prosurvival cyto-
kines including IL-2, IL-4, IL-6, and IL-15 (Park et al., 2004).
This has been postulated as a mechanism to promote survival
of themaximumpossible number of T cells for the limited amount
of IL-7 available (Mazzucchelli and Durum, 2007). Because
a large fraction of Foxo1-deficient T cells were activated and
produced effector cytokines (Figure 3), it was possible that the
downregulation of IL-7R expression in Foxo1-deficient T cells
was a consequence of the heightened cytokine stimulation. To
study whether Foxo1 control of IL-7R expression was via cell-
intrinsic or cell-extrinsic pathways, we generated mixed bone
marrow chimeric mice. T cell-depleted bone marrow cells from
CD45.2+ Foxo1-deficient mice and CD45.1+ WT mice were
transferred either separately or in combination into sublethally
irradiated Rag1/ recipients. All chimeric mice reconstituted
with Foxo1-deficient bone marrow cells developed severe
wasting disease 8 weeks after the transfer. Upon histological
examination, we found heavy mononuclear cell infiltration in
the mucosal lamina propria and the subglandular area of the
colons of these mice (Figure 6A). In contrast, mice reconstituted
with WT bone marrow cells did not develop colitis (Figure 6A). A
higher proportion of splenic CD4+ and CD8+ T cells from the
Foxo1-deficient chimera exhibited an activated phenotype
than did T cells from the WT chimera (Figure 6B) and differenti-
ated to cytokine-producing effector T cells (data not shown).
To determine whether Foxo1 deficiency affected Treg cell
homeostasis under these conditions, we assessed Treg cell
frequencies in these mice. Approximately 30% of CD4+ T cells
from the WT chimera were Treg cells, compared to about 7%
of Foxo1-deficient CD4+ T cells (Figure 6C). These observations
demonstrate an important role for Foxo1 in control of T cell toler-ance, T cell activation, and Treg cell homeostasis in the bone
marrow chimeric mice.
Mixed bone marrow chimeric mice, however, did not develop
colitis (Figure 6A). To examine the reconstitution efficiency ofWT
and Foxo1-deficient bone marrow, we examined the distribution
of CD45.1+ WT T cells and CD45.2+ Foxo1-deficient T cells in
these mice. In the thymus of one of the mixed chimeras, WT
and Foxo1-deficient T precursor cells produced comparable
number of TCR-bhi mature T cells (Figure 6D, top). However, in
the spleen and lymph nodes of this mouse, the number of
CD45.2+ Foxo1-deficient T cells was greatly diminished
compared to that of CD45.1+ WT T cells (Figure 6D, middle
and bottom). Normalized to the reconstitution efficiency of the
thymus, the number of Foxo1-deficient CD4+ and CD8+ T cells
in the periphery were 6%–30% that of WT T cells (Figure 6E).
Similar to T cells from WT or Foxo1-deficient chimeras, Foxo1-
deficient population of CD4+ and CD8+ T cells from the mixed
chimeras expressed lower amounts of IL-7R than did WT popu-
lation in the same mouse (Figure 6F). These observations reveal
a T cell-intrinsic role for Foxo1 in promoting IL7-R expression,
which was associated with the out competition of Foxo1-defi-
cient T cells byWT T cells in the periphery. To determine whether
Foxo1 directly controlled Il7r gene transcription, we searched for
evolutionarily conserved Foxo1-binding sites in the mouse Il7r
promoter. With rVista program, we found three putative Foxo1-
binding sites within the 10 kb Il7r promoter region that were
conserved between mouse and human (Figure S5). To investi-
gate whether Foxo1 directly bound to these DNA elements, we
performed chromatin immunoprecipitation of WT T cells with
Foxo1 or control antibodies. Genomic fragments containing
the proximal Il7r promoter, the 3.7 kb, but not the 9.1 kb, DNA
regions upstream of the translation start site were selectively
enriched with the Foxo1 antibody (Figures 6G and 6H). These
findings support Il7r as a direct Foxo1 target gene in T cells.
A Critical Function of IL-7R in Foxo1 Control of Naive
OT-II T Cell Homeostasis
Foxo1 deficiency in T cells resulted in the activation and differen-
tiation of a fraction of the peripheral T cells (Figure 3). We wished
to determine how the antigen specificity of T cell receptor (TCR)
would influence T cell responses in the absence of Foxo1. To this
end, we crossed Foxo1-deficient mice with OT-II (CD4+ TCR
specific for anOVApeptide) transgenicmice ontoRag1/ back-
ground, in order to exclude the T cell repertoire as a variable.
Similar to T cells on the polyclonal background (Figure 2), defi-
ciency of Foxo1 did not compromise OT-II T cell-positive selec-
tion (Figure S6). In addition, mature thymic OT-II T cells
expressed lower amounts of CD62L and IL-7R (Figure S6), which
was also in line with the polyclonal T cells (Figures 2 and 5).
However, unlike T cells on the polyclonal background, splenic
Foxo1-deficient OT-II T cells maintained a naive CD44lo pheno-
type (Figure 7A). Compared to WT OT-II mice, the number of(D) The percentage of thymic, splenic, and peripheral lymph node (pLN) CD4+Foxp3+ regulatory T (Treg) cells in WT and KOmice at 6 weeks old. These are repre-
sentative results of six mice per group analyzed.
(E) CD4+ and CD8+ T cells isolated from the spleens of WT and KO mice were stimulated with PMA and ionomycin for 4 hr and analyzed for the expression of
IFN-g, IL-4, IL-10, and IL-17 by intracellular cytokine staining. These are representative results of two independent experiments.
(F) Titers of nuclear antibody (NA) and dsDNA antibody (DA) in the sera of control and KOmice aged between 5 and 6months (n = 6). The p values between the two
groups of antibody titers are shown.
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Figure 4. Differential Gene Expression between Wild-type and Foxo1-Deficient Naive T Cells
(A) Comparison of gene expression values between Foxo1/Foxo1 (wild-type, WT) and CD4Cre-Foxo1/Foxo1 (knockout, KO) naive CD4+ and CD8+ T cells. Data
analyses were done with R Console. The genes with 2-fold or more change of expression were marked as red or green circles.
(B) Overlapping of Foxo1-regulated genes in naive CD4+ and CD8+ T cells. Genes with expression values equal or more than 2-fold different betweenWT and KO
T cells are considered significant. The numbers of shared or uniquely regulated genes between CD4+ and CD8+ T cells are indicated.
(C) A sublist of coregulated genes between CD4+ and CD8+ T cells. The genes were analyzed for gene ontology and are grouped as cell-surface molecules,
signaling proteins, nuclear factors, and molecules involved in cell metabolism.mature OT-II T cells was greatly reduced in the spleens and
lymph nodes of Foxo1-deficient OT-II mice by 80%–90%
(Figure 7B). These observations reveal that Foxo1 is essential
for the maintenance of naive OT-II T cells in vivo.364 Immunity 30, 358–371, March 20, 2009 ª2009 Elsevier Inc.As expected, Foxo1-deficient OT-II T cells failed to express
IL-7R (Figure 7C). To determine the functional consequences
of diminished IL-7R expression in Foxo1-deficient T cells, we
crossed Foxo1-deficient mice with IL-7R transgenic (IL-7RTg)
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correct the T cell activation phenotype or significantly affect the
number of Foxo1-deficient T cells on the polyclonal back-
ground (Figure S7 and data not shown). However, the restored
IL-7R expression rescued peripheral T cell number in Foxo1-
deficient OT-II IL-7RTg mice (Figures 7D and 7E), which was
associated with the recovery of Bcl-2 protein expression in
Foxo1-deficient OT-II T cells (Figure 7F). These findings estab-
lish a central role for IL-7R in Foxo1 control of naive T cell
homeostasis.
DISCUSSION
Because of the embryonic lethal phenotype of Foxo1-deficient
mice, the function of Foxo1 in T cells has not been studied
in vivo. We have developed a mouse strain that enabled cell
type-specific deletion of Foxo1 gene via the Cre-loxP system.
In this report, we used CD4-Cre transgenic mice to delete
Foxo1 gene in T cells and explored its role in thymic T cell devel-
opment and peripheral T cell activity. We found that Foxo1 was
not essential for the positive selection of CD4+ and CD8+ T cells,
but was required for the expression of IL-7R and CD62L in
mature thymocytes. Foxo1 deficiency also led to the compro-
mised IL-7R and CD62L expression in naive T cells in the
peripheral lymphoid organs. Diminished expression of IL-7R
was associated with failed IL-7 signaling in Foxo1-deficient
T cells, which resulted in the compromised IL-7-induced T cell
survival in vitro and reduced IL-7-dependent homeostatic pro-
liferation in vivo. During revision of the current manuscript,
Kerdiles et al. (2009) published a report on the use of a different
strain of T cell-specific Foxo1-deficient mice to reveal Foxo1
regulation of IL-7R and CD62L expression similar to findings
in our study. However, the functional significance of diminished
IL-7R expression in Foxo1-deficient T cells was not addressed
in that study. By using a strain of IL-7R transgenic mouse, we
showed that reduced IL-7R expression was responsible for
the homeostasis defects of naive Foxo1-deficient OT-II
T cells. In addition, Foxo1 deficiency caused spontaneous
T cell activation, effector T cell differentiation, and the produc-
tion of autoantibodies in mice. In a bone marrow transfer model,
lack of Foxo1 expression in T cells resulted in colitis. These
observations reveal previously undefined potent and pleiotropic
roles for Foxo1 in control of T cell homeostasis and tolerance
in vivo.
A major finding of the present study was that Foxo1 controlled
naive T cell homeostasis via its regulation of IL-7R expression.
As a transcription factor, Foxo1 can bind to regulatory DNA
sequences on target genes (Obsil and Obsilova, 2008). Indeed,
we identified consensus Foxo1-binding sites in the promoter
region of Il7r gene. We further found direct Foxo1 association
with the proximal Il7r promoter and an evolutionarily conserved
noncoding region 3.7 kb upstream of the translation start site.
Future studies will be needed to test the importance of these
Foxo1 binding sites in control of IL-7R expression in T cells. In
addition, it has been reported that Foxo1 can regulate gene
expression independent of its DNA-binding domain (Ramasw-
amy et al., 2002). In this case, Foxo1 may interact with other
nuclear factors involved in the control of IL-7R expression.
Previous studies have revealed that IL-7R transcription inT cells is positively regulated through proximal promoter region
that contains binding motifs for the transcription factor GABP
(Xue et al., 2004). IL-7R transcription is also subjected to repres-
sion by the transcription repressor Gfi-1 (Park et al., 2004), which
binds to an intronic region of Il7r gene. How Foxo1 interacts with
these transcription factors in control of IL-7R transcription will be
an interesting area for future exploration.
The expression of IL-7R is dynamically regulated at multiple
stages of T cell differentiation (Mazzucchelli and Durum, 2007).
When naive T cells encounter antigen during infection, they
undergo expansion and differentiation. This is associated with
the downregulation of IL-7R expression on most effector
T cells (Huster et al., 2004; Kaech et al., 2003). Stimulation of
T cells via the TCR, costimulatory receptor, and cytokine
signaling pathways also inactivates Foxo1 via PKB-induced
phosphorylation (Peng, 2008). It remains to be determined
whether the downregulation of IL-7R expression on effector
T cells is a consequence of Foxo1 inactivation. It has been shown
that a small subset of the effector CD8+ T cells express high
amounts of IL-7R and differentiate into long-lived memory
CD8+ T cells (Huster et al., 2004; Kaech et al., 2003). The function
of Foxo1 in control of IL-7R expression in memory T cells
warrants further investigation.
In addition to the control of naive OT-II T cell homeostasis,
Foxo1 was required for the inhibition of T cell activation and
differentiation on T cell polyclonal background. It has been
proposed that T cell activation and development of autoimmune
diseases can be caused by T cell lymphopenia (King et al., 2004;
Marleau and Sarvetnick, 2005), which is associated with IL-7-
driven homeostatic T cell proliferation (Calzascia et al., 2008).
Foxo1-deficient naive T cells were depleted and expressed
markedly lower amounts of IL-7R than did Foxo1-deficient
T cells with the activated phenotype, raising the possibility that
T cell activation was a consequence of enhanced IL-7 stimula-
tion. Overexpression of IL-7R via an IL-7R transgene in Foxo1-
deficient T cells largely nullified IL-7R expression difference
between naive and activated T cells, but did not correct the
T cell activation phenotype. These observations suggest that
T cell activation in the absence of Foxo1 was not caused by
defective IL-7R expression. Treg cell number was not reduced
in unmanipulated Foxo1-deficient mice, which is consistent
with a dispensable role for the IL-7R signaling pathway in control
of Treg cell homeostasis (Bayer et al., 2008; Mazzucchelli
et al., 2008; Vang et al., 2008). These findings imply that Foxo1
functions as a T cell-intrinsic regulator of tolerance. The mecha-
nisms by which Foxo1 regulates T cell activation remain to be
determined. Gene expression profiling experiments revealed
hundreds of putative Foxo1 target genes in naive T cells.
However, it is still an open question whether Foxo1 controls
another ‘‘master’’ regulator of T cell tolerance, or alternatively
Foxo1 regulates multiple signaling pathways that collectively
ensure naive T cell quiescence.
Reconstitution of sublethally irradiated Rag1/ mice with
Foxo1-deficient bone marrow cells resulted in severe colitis
that was not observed in unmanipulated Foxo1-deficient mice
aged for 5–6 months. Whole-body irradiation induces tissue
damage and triggers the release of microbes and microbial
products that cause systemic inflammation (Paulos et al.,
2007). It remains to be determined whether the heightenedImmunity 30, 358–371, March 20, 2009 ª2009 Elsevier Inc. 365
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Figure 5. Defective IL-7R Expression and IL-7 Signaling in Foxo1-Deficient T Cells
(A) Expression of CD127 in splenic CD4+ and CD8+ T cells from Foxo1/Foxo1 (wild-type, WT) and CD4Cre-Foxo1/Foxo1 (knockout, KO) mice at 6 weeks old.
CD44loCD62Lhi, CD44hiCD62Llo, or CD44hiCD62Lhi T cells represent naive, effector, and central memory subsets, respectively. ISC stands for the isotype control
antibody. These are representative results of five independent experiments.
(B) Expression of CD127 (IL-7R) in thymic TCR-bhiCD4+ and TCR-bhiCD8+ T cells fromWT and KOmice at 6 weeks old. CD69+CD62Llo or CD69CD62Lhi T cells
represent immature and mature populations, respectively. These are representative results of five independent experiments.
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the development of colitis in Foxo1-deficient chimeras. In
Foxo1-deficient chimeric mice, the number of CD4+Foxp3+ cells
was diminished compared to that in the WT chimeras. Reduced
percentage of Foxo1-deficient Treg cells was also observed in
the mixed chimeric mice that had received both wild-type and
Foxo1-deficient bone marrows. These findings reveal a cell-
intrinsic role for Foxo1 in control of Treg cell homeostasis in irra-
diated mice. Active immune suppression by Treg cells is essen-
tial for T cell tolerance (Sakaguchi et al., 2008). How Foxo1
cross-talks with Treg cells in control of T cell responses will be
an interesting area for future study. In contrast to T cells from
Foxo1-deficient chimeras, Foxo1-deficient T cell populations
from themixed chimeric mice exhibited a naive T cell phenotype.
Replenishment of WT Treg cell in the mixed chimeras might
suppress the activation of Foxo1-deficient T cells. Foxo1-defi-
cient T cells expressed low amounts of IL-7R and were not
competitive to WT T cells in the periphery. Therefore, it is also
possible that Foxo1-deficient T cells were rapidly depleted
upon release from the thymus, before they could be activated
by peripheral antigens. Because T cell activation in unmanipu-
lated Foxo1-deficient mice was not associated with observable
Treg cell defects, Foxo1 likely played an autonomous role in
control of T cell activation.
The nature of the antigens that drive the expansion and differ-
entiation of effector T cells in Foxo1-deficient mice remains to be
fully characterized. Interestingly, Foxo1-deficient OT-II T cells on
the Rag1/ background were not activated. Because OT-II
T cells are specific for the foreign ovalbumin antigen, these
results imply that cognate antigen stimulation is needed for the
activation of Foxo1-deficient T cells. Increased production of
nuclear and dsDNA antibodies in Foxo1-deficient mice further
suggested that self-antigens might be involved in the activation
of T cells. Although we did not observe spontaneous colitis in
Foxo1-deficient mice aged up to 6 months, T cells isolated
from the gut-draining mesenteric lymph node exhibited more
pronounced T cell activation than T cells from the other periph-
eral lymph nodes. Importantly, transfer of bone marrow cells iso-
lated from T cell-specific Foxo1-deficient mice into irradiated
Rag1/ mice led to the development of colitis in recipient
mice. These observations imply that Foxo1 is also critical to
prevent the activation of T cells reactive to commensal bacte-
rium antigens.
In conclusion, in this report, we have uncovered critical func-
tions for Foxo1 in regulation of T cell homeostasis and tolerance.
IL-7R was identified as a Foxo1 target gene involved in Foxo1
maintenance of naive T cells. These findings will advance our
knowledge on the function of Foxo family proteins in the immune
system andmight, in the long term, be exploited for finding cures
for autoimmune diseases and cancer.EXPERIMENTAL PROCEDURES
Mice
Mouse genomic DNA of the Foxo1 genewas isolated from a 129SVBAC library
(Genome Systems). The targeting vector was constructed by cloning three
genomic fragments into the plasmid of pEasy-FLIRT. Linearized targeting
vector was transfected into ES cells (TC1). Homologous recombinants were
identified by Southern blot analysis and were implanted into foster mothers.
Chimeric mice were bred to C57BL/6 mice, and the F1 generation was
screened for germline transmission. The Neo gene was removed by breeding
F1 mice with a strain of actin promoter-driven Flipase transgenic mice (JAX).
Mice carrying the floxed allele of Foxo1 were backcrossed to C57BL/6 for
five to six generations. CD4-Cre transgenic mice, OT-II TCR transgenic (OT-II)
mice, and Foxp3-RFP knockin mice were described previously (Li et al.,
2006b; Wan and Flavell, 2005). IL-7R transgenic (IL-7RTg) mice (Park et al.,
2004) were kindly provided to us by A. Singer (National Cancer Institute). All
mice were maintained under specific pathogen-free conditions. All animal
experimentation was conducted in accordance with institutional guidelines.
Histopathology
Tissues from sacrificed animals were fixed in Safefix II (Protocol) and
embedded in paraffin. 5 mm sections were stained with hematoxylin and eosin.
Immunoblotting
For the analysis of Foxo1 protein expression, FACS-sorted CD4+ T, CD8+ T,
and B cells were extracted with 13 SDS sample buffer. To analyze IL-7-stim-
ulated Stat5 phosphorylation, FACS-sorted naive (CD44loCD62LhiCD25)
CD4+ and CD8+ T cells from WT and Foxo1-deficient mice were left untreated
or treated with 10 ng/ml IL-7 for 20 min and were lyzed with 1 3 SDS sample
buffer. Protein extracts were separated on 8% SDS-PAGE gels and trans-
ferred to PVDF membrane (Millipore). The membranes were probed with anti-
bodies against Foxo1, p38, Stat5, and phosphorylated Stat5 (Cell Signaling).
Chromatin Immunoprecipitation
The chromatin immunoprecipitation analysis was performed as described
previously (Li et al., 2006b). In brief, CD4+ T cells were fixed for 10 min at
room temperature with 10% formaldehyde. After incubation, glycine was
added to a final concentration of 0.125M to ‘‘quench’’ the formaldehyde. Cells
were pelleted, washed once with ice-cold PBS, and then lysed. The lysates
were pelleted, resuspended, and sonicated to reduce DNA length to between
500 and 1000 base pairs. The chromatin was precleared with protein A
agarose beads for 1 hr and then incubated with 5 mg of Foxo1 antibody
(ab39670, Abcam) or control rabbit Ig overnight. The immune complexes
were precipitated with protein A agarose beads, washed, and eluted in 100 ml
of TE with 0.5% SDS and 200 mg/ml proteinase K. Precipitated DNA was
further purified with phenol/chloroform extranction and ethanol precipitation
and was analyzed by quantitative PCR (qPCR). The primers used in the anal-
ysis of binding included: 9201 to 8993: 50-GCC CAC TTT CTC CCT ACC
TT-30 and 50-TCC AGC TAC TTC ACC GAA GC-30; 3856 to 3545: 50-TCT
TTA AGC TTC CCG CAC TC-30 and 50-ACC TCA TCA GCC TTT CAT GG-30;
385 to 88: 50-AAG TGT GGA TTT TGG CCT TG-30 and 50-GAG AGA GGG
AGA CCC AAA CC-30.
Flow Cytometry
Cells from spleens, lymph nodes, or thymus were depleted of erythrocytes by
hypotonic lysis. Cells were incubated with specific antibodies for 15 min on ice
in the presence of 2.4G2 mAb to block FcgR binding. Samples were analyzed(C) Expression of Bcl-2 in splenic CD4+ and CD8+ naive T cells fromWT and KO mice at 8 weeks old. Intracellular staining was performed, and Bcl-2 expression
was determined by flow cytometry.
(D) Naive CD4+ T cells fromWT and KOmice were left untreated (medium) or treated with 10 ng/ml IL-7 for 20min. The amounts of phosphorylated Stat5 and total
Stat5 protein were determined by immunoblotting.
(E) Naive CD4+ and CD8+ T cells fromWT and KOmice were cultured in the absence or presence of increasing doses of IL-7 for 24 hr. Cell apoptosis was exam-
ined by Annexin-V staining.
(F) Naive CD4+ and CD8+ T cells isolated from CD45.2+ KO and CD45.1+ congenic WTmice were labeled with CFSE and cotransferred into Rag1-deficient mice.
The percentage ofWT and KO T cells before (d0) and after (d7) transfer was shown. CFSE dilution indicates cell proliferation. The histograms showed homeostatic
proliferation of the transferred T cells. These are representative results of three independent experiments.
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Figure 6. A Cell-Intrinsic Role for Foxo1 in Control of IL-7R Expression
(A–F) Chimeras were generated by reconstitution of Rag1/ recipients with CD45.1+ wild-type (WT), CD45.2+ CD4-Cre-Foxo1/Foxo1 (knockout, KO), or 1:1
mixed WT and KO bone marrow cells. The chimeric mice were analyzed 8 weeks after the bone marrow transfer. These are representative results of three inde-
pendent experiments.
(A) Development of inflammatory bowel disease in KO chimeric mice. Hematoxylin and eosin staining of the colons of WT, KO, or mixed chimeric mice. These are
representative results of four mice per group analyzed.
(B) Expression of CD44 and CD62L in splenic CD4+ and CD8+ T cells from WT, KO, or mixed chimeras.
(C) Percentage of CD4+Foxp3+ regulatory T cells in the spleens of WT, KO, or mixed chimeras.
(D) Percentage of WT (CD45.1+) and KO (CD45.2+) T cells in the thymus, spleen, and peripheral lymph nodes (pLN) of a mixed chimeric mouse.
(E) Percentage of WT and KO T cells in the spleens and pLNs of the mixed chimeras that are normalized to thymic T cells (mean and SD of eight mixed chimeric
mice). The p values of percentage between the two groups of mice are less than 107.
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Figure 7. Foxo1 Control of IL-7R Expression and Homeostasis of OT-II T Cells
(A) Expression of CD44 and CD62L in splenic OT-II T cells from Foxo1/Foxo1 (wild-type, WT) and CD4Cre-Foxo1/Foxo1 (knockout, KO) mice at 8 weeks old.
These are representative results of three independent experiments.
(B) Number of splenic and lymph node (pLN) OT-II T cells from WT and KO mice aged between 8 and 12 weeks. The p values of cell number between the two
groups of mice are shown.
(C) Expression of CD127 (IL-7R) in splenic OT-II T cells fromWT and KOmice. These are representative results of three independent experiments. ISC stands for
the isotype control antibody.
(D) Percentage of splenic OT-II T cells fromWT, KO,WT IL-7R transgenic (IL-7RTg), and KO IL-7RTgmice at 8 weeks old. These are representative results of three
independent experiments.
(E) CD127 expression in splenic OT-II T cells from WT, KO, WT IL-7RTg, and KO IL-7RTg mice at 8 weeks old.
(F) Bcl-2 expression in splenic OT-II T cells from WT, KO, WT IL-7RTg, and KO IL-7RTg mice at 8 weeks old.with LSR II (Becton Dickinson) and the FlowJo software (Tree Star). Antibodies
against cell-surfacemarkers and Foxp3 were obtained from eBiosciences. For
intracellular cytokine staining, single-cell suspensions of spleens, peripherallymph nodes (pLN), and mesenteric lymph nodes (mLN) were stimulated
with 50 ng/ml phorbol 12-myristate 13-acetate (PMA, Sigma), 1 mM ionomycin
(Sigma), and GolgiStop (BD Biosciences) for 4 hr. After stimulation, cells were(F) Expression of CD127 (IL-7R) in splenic naive (CD44loCD62Lhi) CD4+ andCD8+ T cells fromWT, KO, ormixed chimeras. Expression of CD127 in T cells fromWT
and KO chimeras was plotted (left). Expression of CD127 inWT and KO T cell populations from the samemixed chimeric mouse was plotted (right). ISC stands for
the isotype control antibody.
(G) Alignment of the conserved Foxo1-binding sites (FBS) in mouse and human Il7r gene promoter regions. The consensus Foxo1-binding sequences were
marked in red. The nucleotide numbers are in reference to the translation start site (ATG, A is +1). Asterisks show the conserved nucleotides.
(H) Chromatin immunoprecipitation analysis of Foxo1 binding to the mouse Il7r promoter region. Immunoprecipitates from T cells were analyzed by quantitative
PCR. The results were presented as fold of template enrichment in immunoprecipitates of Foxo1 antibody relative to those of an isotype control antibody (mean
and SD of triplicate immunoprecipitations).
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In Vivo Function of Foxo1 in T Cellsfirst stained with cell-surface marker antibodies, fixed and permeabilized with
a Cytofix/Cytoperm kit (BD Biosciences), and stained with IFN-g and IL-4, or
IL-10 and IL-17 antibodies. Intracellular Foxp3 staining was carried out with
a kit from the eBiosciences. Intracellular Ki-67 staining was performed with
a kit from BD Biosciences. To analyze cell apoptosis, FACS-sorted naive
T cells were cultured in the absence or presence of IL-7 for 24 hr and were
stained with FITC-labeled annexin V (BD Biosciences) according to the manu-
facturer’s instructions.
ELISA
The amounts of dsDNA and nuclear antibodies inmouse sera were determined
with an ELISA kit fromAlpha Diagnostic International. Sera from six pairs ofWT
and Foxo1-deficient mice aged 5–6 months were assayed individually with
1:100 dilution in 1% BSA PBS.
Gene Expression Profiling
Splenic and LN CD44loCD62LhiCD25 naive CD4+ and CD8+ T cells from WT
and Foxo1-deficient mice at 6 to 8 weeks old were purified by FACS-sorting
and lyzed in QIAzol reagent. RNA was isolated with miRNeasy Mini Kit accord-
ing to the manufacturer’s instructions (QIAGEN). Two rounds of RNA amplifi-
cation, labeling, and hybridization to M430 2.0 chips (Affymetrix) were carried
out at the Core Facility of Memorial Sloan-Kettering Cancer Center. All data
analyses were done with R Console. The genes with 2-fold or more change
of expression were considered as Foxo1-dependent genes. The Foxo1-
dependent genes shared by CD4+ and CD8+ T cells were divided into four
categories of cell-surface proteins, signal transduction molecules, nuclear
factors, and protein involved inmetabolism byGene Ontology analysis at web-
site of David Bioinformatics Resource (http://david.abcc.ncifcrf.gov/). The
heat maps were made with R Console.
Treg Cell Suppression Assay
CD4+Foxp3+ regulatory T cells (Treg) were isolated from WT and Foxo1-defi-
cient mice that were bred to the Foxp3-RFP background by FACS sorting of
CD4+RFP+ cells. CD44loCD4+RFP cells sorted from WT mice were labeled
with 4 mM of Carboxyfluorescein diacetate succinimidyl ester (CFSE, Sigma)
at 37C for 10 min, and used as responder T cells (Tresp). 5 3 104 Tresp cells
were cultured in 96-well plates with 105 irradiated splenocytes and 2 mg/ml
CD3 antibody in the absence or presence of 5 3 104 Treg cells for 72 hr.
CFSE dilution was analyzed by FACS.
Adoptive Transfer of T Cells
Splenic and LN CD44loCD62LhiCD25 naive CD4+ and CD8+ T cells from 6- to
8-week-old CD45.1+ congenic C57BL/6 (WT) mice or CD45.2+ Foxo1-
deficient mice were purified by FACS sorting and were labeled with CFSE.
2 3 106 1:1 mixed WT and Foxo1-deficient T cells were injected i.v. to 6- to
8-week-old Rag1/ mice. Mice were sacrificed 7 days after the transfer.
CFSE dilution of WT and Foxo1-deficient T cells in spleens and pLNs were
determined by FACS.
Generation of Bone Marrow Chimeras
Bone marrow cells isolated from 6- to 8-week-old CD45.1+ congenic C57BL/6
(WT) mice or CD45.2+ Foxo1-deficient mice were depleted of erythrocytes by
hypotonic lysis and of T cells and antigen-presenting cells by complement-
mediated cell lysis. 2 3 106 WT, Foxo1-deficient, or 1:1 mixed WT and
Foxo1-deficient bone marrow cells were injected i.v. to 6- to 8-week-old
Rag1/ mice that were sublethally irradiated (600 rad).
Statistical Analyses
Student’s t test was used to calculate statistical significance for difference in
a particular measurement between groups. p < 0.05 was considered statisti-
cally significant.
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